Survival Outcomes for Patients with Indeterminate 18 FDG-PET Scan for Extrahepatic Disease before Liver Resection for Metastatic Colorectal Cancer: A Retrospective Cohort Study Using a Prospectively Maintained Database to Analyze Survival Outcomes for Patients with Indeterminate Extrahepatic Disease on 18FDG-PET Scan before Liver Resection for Metastatic Colorectal Cancer

Annals of Surgery

Volumn 267, Issue 5, 2018, Pages 929-935

  Wong, Geoffrey Yuet Mun ^a   Kumar, Rajiv ^a   Beeke, Carol ^a   Ullah, Shahid ^b   Chen, John ^a   Karapetis, Christos ^a,c   Price, Timothy ^d   Padbury, Rob ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b SOUTH AUSTRALIAN HEALTH AND MEDICAL RESEARCH INSTITUTE   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

^d QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

18 FDG PET scan; extrahepatic disease; hepatic resection; liver metastases; liver resection; metastatic colorectal cancer; survival outcomes

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; COHORT ANALYSIS; COLORECTAL LIVER METASTASIS; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; EXTRAHEPATIC DISEASE; FEMALE; FOLLOW UP; HUMAN; LIVER DISEASE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; MIDDLE AGED; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; CANCER STAGING; COLORECTAL TUMOR; DIAGNOSTIC IMAGING; EPIDEMIOLOGY; LIVER; LIVER TUMOR; MORTALITY; PERITONEUM TUMOR; PROCEDURES; SECONDARY; SOUTH AUSTRALIA; SURVIVAL RATE; TRENDS;

COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PERITONEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SOUTH AUSTRALIA; SURVIVAL RATE;

EID: 85011928498     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000002170     Document Type: Article

References (44)

1. Weiss L, Gundmann E, Torhorst J, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. JPathol. 1986;150:195-203.
2. Manfredi S, Lepage C, Hatem C, et al. Epidemiology and management of liver metastases from colorectal cancer. Ann Surg. 2006;244:254-259.
3. Edge SB, Byrd SR, Compton CC, et al. Colon and rectum. In: Edge SB, Byrd SR, Compton CC, et al., eds. AJCC Cancer Staging Manual. 7th ed., New York, NY: Springer-Verlag; 2010:143-164.
4. Choti MA, Bulkley GB. Management of hepatic metastases. Liver Transpl Surg. 1999;5:65-80.
5. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg. 1990;77:1241-1246.
6. Jamison RL, Donohue JH, Nagorney DM, et al. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg. 1997;132:505-510.
7. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309-321.
8. Choti MA, Sitzmann JV, Tiburi MF, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2000;235:759-766.
9. Tomlinson JS, Jarnagin WR, DeMatteo RP, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007;25:4575-4580.
10. Padman S, Padbury R, Beeke C, et al. Liver only metastatic disease in patients with metastatic colorectal cancer: impact of surgery and chemotherapy. Acta Oncol. 2013;52:1699-1706.
11. Pawlik TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008;13:51-64.
12. Garden OJ, Rees M, Poston GJ, et al. Guidelines for resection of colorectal cancer liver metastases. Gut. 2006;55:iii1-iii8.
13. Fletcher JW, Djulbegovic B, Soares HP, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med. 2008;49:480-508.
14. Flamen P, Hoekstra OS, Homans F, et al. Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET). Eur J Cancer. 2001;37:862-869.
15. Flanagan FL, Dehdashti F, Ogunbiyi OA, et al. Utility of FDG-PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer. Ann Surg. 1998;227:319-323.
16. Huebner RH, Park KC, Shepard JE, et al. A meta-analysis of the literature for whole body FDG PET detection of recurrent colorectal cancer. J Nuc Med. 2000;41:1177-1189.
17. Delbeke D, Vitola JV, Sandler MP, et al. Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med. 1997;38:1196-1201.
18. Fong Y, Saldinger PF, Akhurst T, et al. Utility of 18F-FDG positron emission tomography scanning on selection of patients for resection of hepatic colorectal metastases. Am J Surg. 1999;178:282-287.
19. Valk PE, Abella-Columna E, Haseman MK, et al. Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer. Arch Surg. 1999;134:503-511.
20. Strasberg SM, Dehdashti F, Siegel BA, et al. Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study. Ann Surg. 2001;233:2658-2670.
21. Fernandez FG, Drebin JA, Linehan DC, et al. Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 Fluorodeoxyglucose (FDG-PET). Ann Surg. 2004;240:438-450.
22. Wiering B, Krabbe PFM, Jager GJ, et al. The impact of fluor-18-deoxyglucose- positron emission tomography in the management of colorectal liver metastases. Cancer. 2005;104:2658-2670.
23. Whiteford MH, Whiteford HM, Yee LF, et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum. 2000;43:759-767.
24. Scott AM, Gunawardana DH, Kelly B, et al. PET changes management and improves prognostic stratification in patients with recurrent colorectal cancer: results of a multicenter prospective study. J Nucl Med. 2008;49:1451-1457.
25. Ekberg H, Tranberg KG, Andersson R, et al. Determinants of survival in liver resection for colorectal secondaries. Br J Surg. 1986;73:727-731.
26. Adam R, de Haas RJ, Wicherts DA, et al. Concomitant extrahepatic disease in patients with colorectal liver metastases: when is there a place for surgery? Ann Surg. 2011;253:349-359.
27. Pulitanò C, Bodingbauer M, Aldrighetti L, et al. Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis. Ann Surg Oncol. 2011;18:1380-1388.
28. Zhuang H, Alavi A. 18-fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med. 2002;32:47-59.
29. El-Haddad G, Zhuang H, Gupta N, et al. Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. Semin Nucl Med. 2004;34:313-329.
30. Demura Y, Tsuchida T, Ishizaki T, et al. 18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax. J Nucl Med. 2003;44:540-548.
31. Neo EL, Beeke C, Price T, et al. South Australian clinical registry for metastatic colorectal cancer. ANZ J Surg. 2011;81:352-357.
32. de Jong MC, Pulitano C, Ribero D, et al. Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg. 2009;250:440-448.
33. Pfannschmidt J, Dienemann H, Hoffman H. Surgical resection of pulmonary metastases from colorectal cancer: a systematic review of published series. Ann Thorac Surg. 2007;84:324-348.
34. Maithel SK, Ginsberg MS, D'Amico F, et al. Natural history of patients with subcentimeter pulmonary nodules undergoing hepatic resection for metastatic colorectal cancer. J Am Coll Surg. 2010;210:31-38.
35. Brouquet A, Vauthey JN, Contreras CM, et al. Improved survival after resection of liver and lung colorectal metastases compared with liver-only metastases: a study of 112 patients with limited lung metastatic disease. J Am Coll Surg. 2011;213:62-69.
36. Reilly WT, Nelson H, Schroeder G, et al. Wound recurrence following conventional treatment of colorectal cancer. A rare but perhaps underestimated problem. Dis Colon Rectum. 1996;39:200-207.
37. Silecchia G, Perrotta N, Giraudo G, et al. Abdominal wall recurrences after colorectal resection for cancer: results of the Italian registry of laparoscopic colorectal surgery. Dis Colon Rectum. 2002;45:1172-1177.
38. Thomasset SC, Garcea G, Berry DP. Oesophageal metastasis from colorectal cancer. Case Rep Gastroenterol. 2008;2:40-44.
39. Roth ES, Fetzer DT, Barron BJ, et al. Does colon cancer ever metastasize to bone first? A temporal analysis of colorectal cancer progression. BMC Cancer. 2009;9:274.
40. Santini D, Tampellini M, Vincenzi B. Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study. Ann Oncol. 2012;23:2072-2077.
41. Kim TY, Kim WB, Ryu JS, et al. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma. Laryngoscope. 2005;115:1074-1078.
42. Bae JS, Chae BJ, Park WC, et al. Incidental thyroid lesions detected by FDGPET/CT: prevalence and risk of thyroid cancer. World J Surg Oncol. 2009;7:63.
43. Lièvre A, Leboulleux S, Boige V, et al. Thyroid metastases from colorectal cancer: the Institut Gustave Roussy experience. Eur J Cancer. 2006;42: 1756-1759.
44. Goatman C, Goldsmith PJ, Antonopoulos V, et al. Metastasis of colorectal adenocarcinoma to the thyroid: a case report and review of the literature. Case Rep Surg. 2012;2012:179407.